Related Experiment Videos
Locally advanced pancreatic cancer
Christopher G Willett1, Brian G Czito, Johanna C Bendell
1Department of Radiation Oncology, Duke University Medical Center, Durham, NC 27710, USA. willett@radonc.duke.edu
Summary
Locally advanced pancreatic carcinoma, unresectable due to local invasion, is diagnosed in 40% of patients. Radiotherapy, including external-beam irradiation with chemotherapy or targeted agents, is a key treatment approach.
Area of Science:
- Oncology
- Radiation Oncology
Background:
- Pancreatic carcinoma presents a significant challenge, with approximately 40% of diagnoses showing locally advanced disease.
- Locally advanced pancreatic tumors are often unresectable due to invasion of retroperitoneal vessels.
Purpose of the Study:
- To outline current radiotherapeutic approaches for unresectable pancreatic carcinoma.
- To highlight the role of radiation in managing locally advanced pancreatic cancer.
Main Methods:
- Review of established and emerging radiotherapeutic strategies.
- Discussion of combination therapies involving chemotherapy and targeted agents.
Main Results:
- External-beam irradiation, with or without fluorouracil-based chemotherapy, is a standard treatment.
- Intraoperative irradiation offers an alternative modality.
- Emerging systemic targeted agents are being integrated with external-beam irradiation.
Conclusions:
- Radiotherapy remains a cornerstone in the management of locally advanced pancreatic carcinoma.
- Multimodal approaches combining radiation with systemic therapies are evolving for unresectable tumors.